|
| | |
In This Issue
Welcome to the fall issue of MedConnect, a quarterly newsletter with valuable insights and intelligence on pharmacy benefit management and healthcare. Read on to find out what's to come in this edition... read more
|
|
| |
| |
|
MedMatters
MedImpact News
Learn about the hottest news from MedImpact, from announcements to publications to event updates. ... read more
|
|
|
|
Self-Funded
HDHPs
Use of high deductible health plans with health savings accounts has rapidly increased as premiums have risen and employers move to consumer direct insurance design. Read on to learn about market trends relating to self-funded employers. ... read more
|
|
|
|
Specialty Rx
New and ... Improved?
New, promising therapies for managing cholesterol are coming to the market, but do they offer substantial improvements that justify their high price tags? ... read more
|
|
|
| |
|
340B
HRSA MegaGuidance
In this article we take a preliminary look at the much-anticipated 340B Drug Pricing Program Omnibus Guidance released by the Health Resources and Services Administration on August 28, 2015. ... read more
|
|
|
|
MCO Commercial
Pharmacy Flu Program
Did you know when your members receive a flu vaccination through a retail pharmacy YOU can save up to 50% over the cost of a visit to a physician’s office? ... read more
|
|
|
|
Drug Info
PCSK9 Inhibitors This glimpse at the future treatment of high cholesterol offers a detailed, clinical evaluation of the new cholesterol-lowering therapies. ... read more
|
|
|
| |
|
Top Drugs
Top RA Drugs
This article provides a downloadable report with graphics illlustrating the top rheumatoid arthritis drugs by claim cost and volume. ... read more
|
|
|
|
Upcoming Events Visit With Us
MedImpact regularly participates in conferences, tradeshows and other industry events. Learn where we’ll be speaking, attending and exhibiting throughout the year. ... read more
|
|
|
|
Contact Us
We Want Your Input
Connect with us! If you have questions or suggestions for future articles, please contact us. ... read more
|
|
|
| | | |
|
|
|